PGRP-S promotes hepatocellular carcinoma progression via MAPK/ERK pathway by interaction with TTC1.

Zhu H, Feng S, Lv S, Zhao D, Chang X, Fan S, Wang X, Qian X

DOI: 10.1038/s41598-025-12160-x
Published: 2025 Aug 4
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-025-12160-x,
  title = {PGRP-S promotes hepatocellular carcinoma progression via MAPK/ERK pathway by interaction with TTC1.},
  author = {Zhu H and Feng S and Lv S and Zhao D and Chang X and Fan S and Wang X and Qian X},
  year = {2025},
  journal = {Scientific reports},
  doi = {10.1038/s41598-025-12160-x},
  url = {https://doi.org/10.1038/s41598-025-12160-x}
}

RIS

TY  - JOUR
TI  - PGRP-S promotes hepatocellular carcinoma progression via MAPK/ERK pathway by interaction with TTC1.
AU  - Zhu H
AU  - Feng S
AU  - Lv S
AU  - Zhao D
AU  - Chang X
AU  - Fan S
AU  - Wang X
AU  - Qian X
PY  - 2025
JO  - Scientific reports
DO  - 10.1038/s41598-025-12160-x
UR  - https://doi.org/10.1038/s41598-025-12160-x
ER  -

APA

H, Z., S, F., S, L., D, Z., X, C., S, F., X, W., & X, Q. (2025). PGRP-S promotes hepatocellular carcinoma progression via MAPK/ERK pathway by interaction with TTC1.. Scientific reports. https://doi.org/10.1038/s41598-025-12160-x

Source records

pubmed · retrieved 2026-09-25T23:12:54.131Z
europe-pmc · retrieved 2026-09-25T23:12:54.147Z
doaj · retrieved 2026-09-25T23:12:54.154Z